Disease-drug database for pharmacogenomic-based prescribing
نویسندگان
چکیده
منابع مشابه
Drug-induced arrhythmia: pharmacogenomic prescribing?
Drug-induced Torsades de Pointes is a rare, unpredictable, and life-threatening serious adverse event. It can be caused by both cardiac and non-cardiac drugs and has become a major issue in novel drug development and for the regulatory authorities. This review describes the problem, predisposing factors, and the underlying genetic predisposition as it is understood currently. The future potenti...
متن کاملDrug combinations for bipolar spectrum disorders: evidence-based prescribing or prescribing-based evidence?
1298 J Clin Psychiatry 65:10, October 2004 reatment of bipolar spectrum disorders today is a hot topic, with many new agents now available and many new combinations being touted. However, clinical practice may not always be “in synch” with clinical research, since the treatment of bipolar spectrum disorders with monotherapies as well as with combinations of drugs may now be the least evidence-b...
متن کاملAppropriate Drug Prescribing for Cardiovascular Disease in the Elderly
Cardiovascular disease is one of the leading causes of morbidity and mortality in persons older than 65 years. Hospitalizations due to heart failure have doubled over the past 20 years. Two thirds of myocardial infarcts occur in patients older than 65 [1]. Many articles have been published on appropriate use of drug therapy in the elderly, and the underuse of potentially beneficial therapy has ...
متن کاملFor Asians only? The perils of ancestry-based drug prescribing.
Perry W. Payne, Jr. The term “personalized medicine” increasingly has come to mean the use of genetic testing in prescribing pharmaceutical products.1 The scientific basis of this approach to medicine is that, because of genetic variations, humans differ in their response to treatments. This observation is the cornerstone of pharmacogenetics and pharmacogenomics. Ethical problems sometimes aris...
متن کاملDrug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests.
D h n a p F s i ( t m s p t n t n d f r C i i l rom Clinical Pharmacology, AstraZeneca, Mölndal; Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis; Department of Biology (Galton Lab), University College London, London; Center for Drug Evaluation and Research, Food and Drug Administration, Rockville; School of Pharmacy, University of California San Francisco,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Pharmacology & Therapeutics
سال: 2016
ISSN: 0009-9236
DOI: 10.1002/cpt.364